Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04400474
Title Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN)
Acronym CABATEN
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trias i Pujol - ICO Badalona Badalona Barcelona 08916 Spain Details
Hospital Duran i Reynals - ICO L'Hospitalet L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Hospital General Universitario Elche Alicante 03010 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
MD Anderson Cancer Center Madrid 28033 Spain Details
Hospital Universitario Ramón y Cajal Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario La Paz Madrid 28046 Spain Details
Hospital General Universitario Morales Meseguer Murcia 30008 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
Hospital Universitario Central de Asturias Oviedo 33011 Spain Details
Hospital Universitario Marqués de Valdecilla Santander 39008 Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
Hospital Universitario de Canarias Tenerife 38320 Spain Details
Hospital Universitario Miguel Servet Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field